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Supplementary Figure 1 . Analysis of stem cell (SC) number, hair follicle density and SC fate-determining factors in ILK-K5 mice (a) Immunofluorescence staining for ILK (red) and K14 (green). ILK staining is not detected in hair follicles (HFs) and interfollicular epidermis (IFE) (asterisks) of ILK-K5 mice at P21, whereas the dermal papilla (DP) is positive for ILK (arrowhead). Scale bar 50 μm. (b) Representative plots of FACS analyses with antibodies against CD34 and α6 integrin from P21 and P57 epidermis. ILK-K5 mice show reduced amounts of CD34 + /α6 hi HFSCs. (c) Hematoxylin/eosin staining of P21 skin (scale bars 100 μm). No difference in HF density between control and ILK-K5 mice is observed (mean ± SEM; n=3; ns=not significant, p=0.70, Mann-Whitney). (d) RT-qPCR analysis of key transcription factors required to establish bulge SC fate. No significant difference is observed in expression of Lhx2 or Nfatc1. Sox9 expression is slightly increased (mean ± SEM; n=4; ns=not significant, p>0.2817; *p=0.0211, Mann-Whitney). (e) Immunofluorescence staining for Nfatc1 (left) and Sox9 (right) at P21. Scale bar 25 μm. (e) Quantification of proliferation within tumours using the marker Ki67 shows no significant difference in proliferation between control and ILK-K5 tumours (mean ±SEM; n=3; ns=not significant, p=0.70, Mann-Whitney).
(f) Quantification of apoptosis within tumours using Tunel staining shows no significant difference in tumour cell apoptosis in control and ILK-K5 mice (mean ± SEM; n=3; p=0.344, Mann-Whitney). 
